Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes

University of Alabama at Birmingham, United States of America
PLoS ONE (Impact Factor: 3.23). 03/2014; 9(3):e89754. DOI: 10.1371/journal.pone.0089754
Source: PubMed


Bladder radiotherapy is a management option for carefully selected patients with muscle-invasive bladder cancer. However, the inability to visualize the tumor site during treatment and normal bladder movement limits targeting accuracy and increases collateral radiation. A means to accurately and reliably target the bladder during radiotherapy is needed.
Eighteen consecutive patients with muscle-invasive bladder cancer (T1-T4) elected bladder-preserving treatment with maximal transurethral resection (TUR), radiation and concurrent chemotherapy. All underwent endoscopic placement of 24-K gold fiducial markers modified with micro-tines (70 [2.9×0.9 mm.]; 19 [2.1×0.7 mm.) into healthy submucosa 5-10 mm. from the resection margin, using custom-made coaxial needles. Marker migration was assessed for with intra-op bladder-filling cystogram and measurement of distance between markers. Set-up error and marker retention through completion of radiotherapy was confirmed by on-table portal imaging.
Between 1/2007 and 7/2012, a total of 89 markers (3-5 per tumor site) were placed into 18 patients of mean age 73.6 years. Two patients elected cystectomy before starting treatment; 16/18 completed chemo-radiotherapy. All (100%) markers were visible with all on-table (portal, cone-beam CT), fluoroscopy, plain-film, and CT-scan imaging. In two patients, 1 of 4 markers placed at the tumor site fell-out (voided) during the second half of radiotherapy. All other markers (80/82, 98%) were present through the end of radio-therapy. No intraoperative (e.g. uncontrolled bleeding, collateral injury) or post-operative complications (e.g. stone formation, urinary tract infection, post-TUR hematuria >48 hours) occurred. Use of micro-tined fiducial tumor-site markers afforded a 2 to 6-fold reduction in bladder-area targeted with high-dose radiation.
Placement of the micro-tined fiducial markers into the bladder was feasible and associated with excellent retention-rate and no complications. All markers were well-visualized during radiotherapy with all imaging modalities. Bladder fiducial markers improve targeting accuracy, and may increase treatment efficacy and reduce morbidity from collateral radiation.

Download full-text


Available from: Maxwell V Meng, Mar 14, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective Bladder motion necessitates large target expansions for organ-preserving treatment of muscle-invasive bladder cancer. These volumes prevent radiation dose escalation and exacerbate treatment-associated morbidity. The use of gold seed markers (GSMs) for improved tracking of the tumor bed during radiotherapy was therefore investigated. Methods Nine consecutive patients with muscle-invasive bladder cancer undergoing bladder preservation therapy from August 2012 through October 2013 underwent maximal transurethral resection of bladder tumor, cystoscopic placement of tumor bed GSMs, and chemoradiation. Continuous orthogonal X-ray imaging for robotic-assisted intensity-modulated radiotherapy (IMRT), daily megavoltage imaging, or both were used to localize GSMs. Results Less than 5 % of intra-fraction GSM and tumor centroid movements were >4 mm across 481 orthogonal images obtained during robotic-assisted IMRT. Patients receiving linear accelerator- and helical tomotherapy-based radiation underwent a total of 246 daily megavoltage imaging sessions, during which <5 % of inter-fraction GSM and tumor centroid movements were >10 mm. A cumulative dose-population algorithm accounting for both systematic and random errors corroborated these findings. Both intra- and inter-fraction displacements were approximately twofold greater for GSMs in the superior half of the bladder (p = 0.03) and in patients with average bladder volume >100 mL (p < 0.0001). Conclusions This is the first case series of intra-fraction GSM tracking for organ-preserving treatment of muscle-invasive bladder cancer. The data suggest that GSM tracking during radiotherapy for bladder cancer is feasible and associated with minimal intra- and inter-fraction displacement. With prospective investigation, this technique may be used to minimize target volumes and reduce radiation-associated toxicity.
    No preview · Article · Sep 2014 · International journal of radiation oncology, biology, physics
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Radical cystectomy is a standard treatment of nonmetastatic, muscle-invasive bladder cancer. Treatment with trimodality therapy consisting of maximal transurethral resection of the bladder tumor followed by concurrent chemotherapy and radiation has emerged as a method to preserve the native bladder in highly motivated patients. Several factors can affect the likelihood of long-term bladder preservation after trimodality therapy and therefore should be taken into account when selecting patients. New radiation techniques such as intensity modulated radiation therapy and image-guided radiation therapy may decrease the toxicity of radiotherapy in this setting. Novel chemotherapy regimens may improve response rates and minimize toxicity. Published by Elsevier Inc.
    Full-text · Article · May 2015 · Urologic Clinics of North America
  • [Show abstract] [Hide abstract]
    ABSTRACT: This is a review of select 2014 English language publications in the domain of bladder conserving treatment for patients with localized invasive urothelial vesical cancer. The intention is to summarize the avenues of research being pursued to improve the success of this management strategy. Directions being investigated are enhancement to bladder tumor control, amelioration of treatment toxicity, and individualization of treatment. Although the results reported are clearly beneficial, what is of more value is the appreciation of the multipronged direction of the research being undertaken to firmly ensconce this organ preserving strategy within the clinical armamentarium that urooncologists can bring to bear in caring for the individual patient diagnosed with bladder cancer.
    No preview · Article · Jul 2015 · Current opinion in supportive and palliative care
Show more